ChemicalBook > Product Catalog >API >Antibiotics >Cephalosporins Drugs >Ceftibuten

Ceftibuten

Ceftibuten Structure
CAS No.
97519-39-6
Chemical Name:
Ceftibuten
Synonyms
cephem;Ceftibutene;s7432;7432S;CS-1355;CEFTIBUTEN;Cedax:Isocef;cis-ceftibutin;cis-Ceftibuten;antibiotic7432s
CBNumber:
CB7299436
Molecular Formula:
C15H14N4O6S2
Molecular Weight:
410.42
MOL File:
97519-39-6.mol
MSDS File:
SDS
Modify Date:
2023/5/18 11:31:19

Ceftibuten Properties

Boiling point 966℃
Density 1.75±0.1 g/cm3(Predicted)
RTECS XI0367220
Flash point >110°(230°F)
storage temp. Keep in dark place,Sealed in dry,2-8°C
solubility Soluble in aqueous solutions. Also soluble in DMSO
form powder
pka 2.99±0.50(Predicted)
color white to beige

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H332-H334
Precautionary statements  P261-P271-P304+P340-P312-P261-P285-P304+P341-P342+P311-P501
WGK Germany  3

Ceftibuten price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML0037 Ceftibuten hydrate ≥98% (HPLC) 97519-39-6 10MG ₹9948.18 2022-06-14 Buy
Sigma-Aldrich(India) SML0037 Ceftibuten hydrate ≥98% (HPLC) 97519-39-6 50MG ₹39900.95 2022-06-14 Buy
Product number Packaging Price Buy
SML0037 10MG ₹9948.18 Buy
SML0037 50MG ₹39900.95 Buy

Ceftibuten Chemical Properties,Uses,Production

Description

Ceftibuten is a new, once daily, orally active cephalosporin introduced as a treatment of Gram-negative bacteria-related urinarylrespiratory tract and gynecological infections. In vitro studies of 359 strains of Gram-negative bacteria demonstrated that ceftibuten was superior to cefaclor and as active or slightly more active than cefixime and cefteram.

Uses

anorexic, antidepressant, inhibitor of 5HT, norepinephrine & dopamine uptake

Definition

ChEBI: A third-generation cephalosporin antibiotic with a [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino substituent at the 7 position of the cephem skeleton. An orally-administered agent, ceftibuten is used as the dihydrate to tre t urinary-tract and respiratory-tract infections.

Antimicrobial activity

A semisynthetic cephalosporin formulated as the dihydrate for oral administration.
It exhibits good activity against many Gram-negative bacilli, but its activity against Gram-positive cocci is very poor. It is stable to hydrolysis by the common plasmid-mediated β-lactamases, but not derepressed chromosomal enzymes .
It is rapidly and almost completely absorbed by mouth and is excreted in the urine with a half-life of 1.5–3 h. An oral dose of 400 mg achieves a peak plasma concentration of around 15 mg/L. Binding to plasma proteins is 65–77%.
Side effects mostly consist of mild gastrointestinal symptoms and mild liver function test changes. Clinical trials have mainly been conducted in urinary tract and respiratory tract infections which, despite the poor in-vitro activity against Str. pneumoniae, have shown ceftibuten to be as efficacious as comparator agents.

General Description

Chemical structure: ?-lactam

Pharmacokinetics

Ceftibuten is highly (75–90%) absorbed on oral administration, but this is decreased significantly by food. Being lipophilic and acidic, it is significantly (65%) serum protein bound. Some isomerization of the geometry of the olefinic linkage appears to take place in vivo before excretion.

Clinical Use

Ceftibuten (Cedax) is a recently introduced, chemicallynovel analog of the oximino cephalosporins in which anolefinic methylene group (C=CHCH2-) with Z stereochemistryhas replaced the syn oximino (CBNO-) group.
This isosteric replacement yields a compound that retainsresistance to hydrolysis catalyzed by many β-lactamases,has enhanced chemical stability, and is orally active. Oralabsorption is rapid and nearly complete. It has the highestoral bioavailability of the third-generation cephalosporins.Ceftibuten is excreted largely unchanged in the urine andhas a half-life of about 2.5 hours. Plasma protein binding ofthis cephalosporin is estimated to be 63%.
Ceftibuten possesses excellent potency against mostmembers of the Enterobacteriaceae family, H. influenzae,Neisseria spp., and M. catarrhalis. It is not active against S.aureus or P. aeruginosa and exhibits modest antistreptococcal activity. Ceftibuten is recommended in the managementof community-acquired respiratory tract, urinary tract, andgynecological infections.

Ceftibuten Preparation Products And Raw materials

Global( 198)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Nectar Lifesciences Ltd +91-9357244445 +91-9357244445 Punjab, India 29 58 Inquiry
Orchid Pharma Ltd. (Formerly Known as Orchid Chemicals and Pharmaceuticals Ltd.) +91-4428244254 +91-4428244254 Tamil Nadu, India 28 58 Inquiry
Suvan LifeSciences (formerly Sansh Biotech Pvt Ltd) +91-1142631798 +91-9899000024 New Delhi, India 55 58 Inquiry
Akums Lifesciences Ltd +91-1147511000 +91-1147511000 New Delhi, India 38 58 Inquiry
Athos Chemicals 91-9998858909 Gujarat, India 315 58 Inquiry
Sai Prathyu Marketing 91-9666672409 Hyderabad, India 162 58 Inquiry
ORCHID PHARMA LIMITED +91–44–2744 4471/72/73/74/75/76/77/78 New Delhi, India 32 58 Inquiry
Hetero Drugs Limited 08048372500Ext 439 Hyderabad, India 174 58 Inquiry
KPS Chemicals & Pharmaceuticals 91--8469484608 Gujarat, India 240 58 Inquiry
Shivam Pharma Chemicals 91-22-26403900 Maharashtra, India 656 58 Inquiry

Ceftibuten Spectrum

(6r-(6-alpha,7-beta(z)))-yl)-4-carboxy-1-oxo-2-butenyl)amino)-8-oxo [6R-[(6α,7β(Z)]]-7-[[2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-5-thia-1-azabi-cyclo[4.2.0]oct-2-ene-2-carboxylic acid Cedax:Isocef (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (6R,7R)-7-[[(Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-2-butenoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid (6R,7R)-7α-[[(Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid CS-1355 antibiotic7432s cephalosporin7432-s cephem cis-ceftibutin s7432 CEFTIBUTEN 7-[2-(2-amino-1,3-thiazol-4-yl)-4-carboxyisocrotonamide]-3-cephem-4-carboxylic acid 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-, (6R,7R)- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]- 7432S Ceftibuten (SCH 39720) Ceftibutene cis-Ceftibuten 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-, (6R,7R)- Ceftibuten USP/EP/BP 97519-39-6 C15H14N4O6S2 MERIDIA API